This study investigates if Terazosin can improve metabolism in PD.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Enrollment
120
This drug increases glycolysis in Parkinson's disease.
Placebo control for Terazosin
University of Iowa
Iowa City, Iowa, United States
ATP
Changes in whole-blood ATP relative to baseline at 6 weeks and 1.5 years
Time frame: at 1.5 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.